AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Xeris Biopharma Holdings, Inc.

$10.71 +$3.36 (+45.71%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$10.75
Day Range
$10.52$10.87
Year Range
$5.25$11.42
Market Cap
1.95B
AVG Volume
2.26M
Trailing/Forward PE
-110.3/31.11
PEG ratio
0.9
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XERS Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2335.41M
26 Q1314.85M
25 Q4291.85M
25 Q3266.14M
25 Q2246.03M
25 Q1222.55M
24 Q4203.07M
24 Q3187.36M
24 Q2181.41M
24 Q1171.36M
Net Income (USD) · TTM
-80M-60M-40M-20M020M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XERS Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-17.16M
26 Q112.01M
25 Q4554K
25 Q3-15.64M
25 Q2-32M
25 Q1-45.08M
24 Q4-54.84M
24 Q3-63.11M
24 Q2-59.56M
24 Q1-64.4M
Operating Income (USD) · TTM
-50M-25M025M50M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XERS Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q236.59M
26 Q135.9M
25 Q424.9M
25 Q39.8M
25 Q2-9.82M
25 Q1-22.49M
24 Q4-33.65M
24 Q3-45.17M
24 Q2-37.19M
24 Q1-44.98M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: XERS

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Xeris Biopharma Holdings, Inc.
XERS
Stockpicker

Video analysis: XERS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: XERS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.